What is zotatifin?
Zotatifin is the investigational medication being studied in the Propel study. Investigational means that zotatifin has not been approved to use for COVID-19, except in research studies.
How does zotatifin work?
Zotatifin is designed to stop the SARS-CoV-2 virus from growing and multiplying, which may help prevent COVID-19 symptoms from becoming more severe.
Have other people used zotatifin?
Yes, participants in another ongoing study have received zotatifin as a therapy for cancer. The Propel study is the first time people will take zotatifin for COVID-19.